Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study

British Journal of Haematology

Volumn 154, Issue 5, 2011, Pages 644-653

  Garbe, Edeltraut ^a,b   Andersohn, Frank ^b   Bronder, Elisabeth ^b   Klimpel, Andreas ^b   Thomae, Michael ^c   Schrezenmeier, Hubert ^d   Hildebrandt, Martin ^e   Späth Schwalbe, Ernst ^f   Grüneisen, Andreas ^g   Mayer, Beate ^b   Salama, Abdulgabar ^b   Kurtal, Hanife ^b  

^a UNIVERSITY OF BREMEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Abteilung Innere Medizin Gastroenterologie   (Germany)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f Vivantes Klinikum Spandau   (Germany)

^g VIVANTES KLINIKUM NEUKÖLLN   (Germany)

Author keywords

Berlin case control surveillance study; Case control study; Causality assessment; Drug induced; Immune haemolytic anaemia

Indexed keywords

AMBROXOL; AMIODARONE; AMOXICILLIN; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BETA LACTAM ANTIBIOTIC; CARDIOVASCULAR AGENT; CEFTRIAXONE; CEFUROXIME; CHLORAMBUCIL; CINEOLE; CIPROFLOXACIN; CLONIDINE; CLOPIDOGREL; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DICLOFENAC; FLUDARABINE; GLUCOCORTICOID; GRANISETRON; IBUPROFEN; LEVODOPA; LORAZEPAM; METFORMIN; METHYLDOPA; OMEPRAZOLE; OXALIPLATIN; PIPERACILLIN; UNINDEXED DRUG; ZIPRASIDONE;

ADULT; AGED; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD TRANSFUSION; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG CLASSIFICATION; DRUG EXPOSURE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PATIENT SELECTION; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; BERLIN; BETA-LACTAMS; CASE-CONTROL STUDIES; CIPROFLOXACIN; DICLOFENAC; FEMALE; HUMANS; LORAZEPAM; MALE; MIDDLE AGED; ODDS RATIO; PHARMACEUTICAL PREPARATIONS; PIPERACILLIN; POPULATION SURVEILLANCE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; VIDARABINE; YOUNG ADULT;

EID: 80051590150     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08784.x     Document Type: Article

References (36)

1. Ahrens, N., Genth, R. & Salama, A. (2002) Belated diagnosis in three patients with rifampicin-induced immune haemolytic anaemia. British Journal of Haematology, 117, 441-443.
2. Ahrens, N., Genth, R., Kiesewetter, H. & Salama, A. (2006) Misdiagnosis in patients with diclofenac-induced hemolysis: new cases and a concise review. American Journal of Hematology, 81, 128-131.
3. Andersohn, F., Bronder, E., Klimpel, A. & Garbe, E. (2004) Proportion of drug-related serious rare blood dyscrasias: estimates from the Berlin Case-Control Surveillance Study. American Journal of Hematology, 77, 316-318.
4. Arndt, P.A. & Garratty, G. (2005) The changing spectrum of drug-induced immune hemolytic anemia. Seminars in Hematology, 42, 137-144.
5. Arndt, P., Garratty, G., Isaak, E., Bolger, M. & Lu, Q. (2009) Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption. Transfusion, 49, 711-718.
6. Aydogdu, I., Ozerol, I.H., Tayfun, E. & Harputluoglu, M. (1997) Autoimmune haemolytic anaemia and thrombocytopenia associated with ciprofloxacin. Clinical and Laboratory Haematology, 19, 223.
7. Bastion, Y., Coiffier, B., Dumontet, C., Espinouse, D. & Bryon, P.A. (1992) Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia. Annals of Oncology, 3, 171-172.
8. Boeger, R. & Schmidt, G. (2010) Antirheumatika und Antiphlogistika. In: Arzneiverordnungsreport (ed. by U. Schwabe & D. Paffrath), pp. 425-444. Springer, Heidelberg.
9. Cobo, F., De Celis, G., Pereira, A., Latorre, X., Pujadas, J. & Albiol, S. (2007) Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature. Anti-Cancer Drugs, 18, 973-976.
10. Garratty, G. (2004) Review: drug-induced immune hemolytic anemia - the last decade. Immunohematology, 20, 138-146.
11. Garratty, G. (2010) Immune hemolytic anemia associated with drug therapy. Blood Reviews, 24, 143-150.
12. Garratty, G., Postoway, N., Schwellenbach, J. & McMahill, P.C. (1991) A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis. Transfusion, 31, 176-179.
13. Garratty, G., Nance, S., Lloyd, M. & Domen, R. (1992) Fatal immune hemolytic anemia due to cefotetan. Transfusion, 32, 269-271.
14. Hodgson, K., Ferrer, G., Montserrat, E. & Moreno, C. (2011) Chronic lymphocytic leukemia and autoimmunity: a systematic review. Haematologica, 96, 752-761.
15. Johnson, S., Smith, A.G., Loffler, H., Osby, E., Juliusson, G., Emmerich, B., Wyld, P.J. & Hiddemann, W. (1996) Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL. Lancet, 347, 1432-1438.
16. Johnson, S.T., Fueger, J.T. & Gottschall, J.L. (2007) One center's experience: the serology and drugs associated with drug-induced immune hemolytic anemia--a new paradigm. Transfusion, 47, 697-702.
17. Koutras, A.K., Makatsoris, T., Paliogianni, F., Kopsida, G., Onyenadum, A., Gogos, C.A., Mouzaki, A. & Kalofonos, H.P. (2004) Oxaliplatin-induced acute-onset thrombocytopenia, hemorrhage and hemolysis. Oncology, 67, 179-182.
18. Lai, J.I. & Wang, W.S. (2009) Acute hemolysis after receiving oxaliplatin treatment: a case report and literature review. Pharmacy World and Science, 31, 538-541.
19. Lim, S. & Alam, M.G. (2003) Ciprofloxacin-induced acute interstitial nephritis and autoimmune hemolytic anemia. Renal Failure, 25, 647-651.
20. MacKay, A.D. & Mehta, A. (1995) Autoimmune haemolytic anaemia associated with ciprofloxacin. Clinical and Laboratory Haematology, 17, 97-98.
21. Meyer, O., Hackstein, H., Hoppe, B., Gobel, F.J., Bein, G. & Salama, A. (1999) Fatal immune haemolysis due to a degradation product of ceftriaxone. British Journal of Haematology, 105, 1084-1085.
22. Moreno, C., Hodgson, K., Ferrer, G., Elena, M., Filella, X., Pereira, A., Baumann, T. & Montserrat, E. (2010) Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance. Blood, 116, 4771-4776.
23. Myint, H., Copplestone, J.A., Orchard, J., Craig, V., Curtis, D., Prentice, A.G., Hamon, M.D., Oscier, D.G. & Hamblin, T.J. (1995) Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia. British Journal of Haematology, 91, 341-344.
24. Nishida, H., Murase, T., Ueno, H., Park, J.W., Yano, T. & Ikeda, Y. (2006) Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia. Leukemia Research, 30, 1589-1590.
25. Petz, L.D. & Garratty, G. (1980) Acquired Immune Hemolytic Anemias. Churchill Livingstone, Philadelphia.
26. Petz, L.D. & Garratty, G. (2004) Immune Hemolytic Anemias, 2nd edn, pp. 261-317. Churchill Livingston, Philadelphia.
27. Salama, A. (2009) Drug-induced immune hemolytic anemia. Expert Opinion on Drug Safety, 8, 73-79.
28. Salama, A. & Mueller-Eckhardt, C. (1985) The role of metabolite-specific antibodies in nomifensine-dependent immune hemolytic anemia. New England Journal of Medicine, 313, 469-474.
29. Salama, A., Gottsche, B. & Mueller-Eckhardt, C. (1991) Autoantibodies and drug- or metabolite-dependent antibodies in patients with diclofenac-induced immune haemolysis. British Journal of Haematology, 77, 546-549.
30. Salama, A., Kroll, H., Wittmann, G. & Mueller-Eckhardt, C. (1996) Diclofenac-induced immune haemolytic anaemia: simultaneous occurrence of red blood cell autoantibodies and drug-dependent antibodies. British Journal of Haematology, 95, 640-644.
31. Seltsam, A. & Salama, A. (2000) Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature. Intensive Care Medicine, 26, 1390-1394.
32. The Uppsala Monitoring Centre. (2010) The use of the WHO-UMC system for standardised case causality assessment. Available at: Accessed May 2011.
33. Tosti, S., Caruso, R., D'Adamo, F., Picardi, A., Ali, E.M., Girelli, G., Mauro, F.R., Maurillo, L. & Amadori, S. (1992) Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment. Annals of Hematology, 65, 238-239.
34. Weiss, R.B., Freiman, J., Kweder, S.L., Diehl, L.F. & Byrd, J.C. (1998) Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia. Journal of Clinical Oncology, 16, 1885-1889.
35. WHO Collaborating Centre for Drug Statistics Methodology. (2011) ATC. Structure and principles. Available at: Accessed May 2011.
36. Yurek, S., Riess, H., Kreher, S., Dorken, B. & Salama, A. (2010) Fatal immune haemolysis due to antibodies to individual metabolites of 5-fluorouracil. Transfusion Medicine, 20, 265-268.